No therapeutic, cosmetic, or medical claims are made
Oct 20: Nearly two years ago, the FDA approved BioMarins Voxzogo (vosoritide) as the first therapy for achondroplasia, a rare genetic disorder that causes the most common form of dwarfismfueling ongoing controversy within the dwarfism community about such treatments
The researchers said this response, together with other stress molecules released by the placenta, helps explain why preeclampsia affects the whole body and can become serious
According to this case, the drug was administered 5 times, and around 2 h after each of the infusions this patient presented severe panic attacks, demonstrating some association of the drug with anxiety symptoms and suicidal behavior in rare cases, highlighting the need for a mental status evaluation before the initiation of the therapy and frequent follow-up by mental health professionals (Roblin et al., 2006)